We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Oscillating Microscopic Beads Used for Biochip

By LabMedica International staff writers
Posted on 10 Oct 2012
Microscopic magnetic beads that can be labeled with biomolecules such as antibodies, causes them to bind to specific proteins or cells for diagnostic purposes. More...


The key to this method was finding a way to capture individual beads and set them oscillating by applying a variable magnetic field and the rate of their oscillation can then be measured to assess the size of the beads.

A team of scientists at Massachusetts Institute of Technology (MIT; Cambridge, MA, USA) has figured out a way to use this basic principle, on a microscopic scale, to carry out biomedical tests that could eventually lead to fast, compact and versatile medical-testing devices. The beads are placed in a biological sample, biomolecules attach to their surfaces, making the beads larger and this change that can then be detected through the biomolecules effect on the beads’ oscillation. This would provide a way to detect exactly how much of a target biomolecule is present in a sample, and provide a way to give a virtually instantaneous electronic readout of that information.

This technique, for the first time, allows these beads, which are each about one micrometer in diameter, to be used for precise measurements of tiny quantities of materials. This could, for example, lead to tests for disease agents that would need just a tiny droplet of blood and could deliver results instantly, instead of requiring laboratory analysis. The dual functionality of domain walls as both bead carriers and sensors is a promising platform for the development of lab-on-a-bead technologies.


Besides being potentially quicker and requiring a far smaller biological sample to produce a result, such a device would be more flexible than existing chip-based biomedical tests. While most such devices are specifically designed to detect one particular kind of protein or disease agent, this new device could be used for a wide variety of different tests, simply by inserting a fresh batch of fluid containing beads coated with the appropriate reactant. After the test, the material could be flushed out, and the same chip used for a completely different test by inserting a different type of magnetic beads.

There are dozens of types of magnetic beads commercially available that can be coated to react with many different biological materials; therefore, such a test device could have enormous flexibility. The team used magnetic beads of different sizes to demonstrate that their system is capable of detecting size differences corresponding to those between particles that are bound to biological molecules and those that are not. The study was published online on August 21, 2012, in the journal Lab on a Chip.

Related Links:
Massachusetts Institute of Technology


New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Staining System
RAL DIFF-QUIK
New
Candida Glabrata Test
ELIchrom Glabrata
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.